Addus HomeCare initiated with an Outperform at JMP Securities

JMP Securities analyst Constantine Davides initiated coverage of Addus HomeCare (ADUS) with an Outperform rating and $150 price target Addus is one of the country’s largest providers of home-based personal care and clinical services, the analyst tells investors in a research note. The firm says the company’s personal care-centered approach differs from other more clinically-centered providers which have attempted to add personal care only after building clinical services, with limited success. It sees the Gentiva acquisition driving growth in 2025.